Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.

Hematology/oncology clinics of North America - 1 Jun 2015

Sperati C John, Moliterno Alison R

Abstract excerpt

Thrombotic microangiopathies (TMA) such as atypical hemolytic uremic syndrome (aHUS) have evolved from rare, fulminant childhood afflictions to uncommon diseases with acute and chronic phases involving both children and adults. Breakthroughs in complement and coagulation regulation have allowed redefinition of specific entities despite substantial phenotypic mimicry. Reconciliation of phenotypes and delivery of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADAM Proteins
Share to ADAMTS13 Protein
Share to Atypical Hemolytic Uremic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement System Proteins

Share to Diagnosis, Differential

Share to Genetic Testing

Share to Genetic Variation

Source

Identifiers

PMID: 26043391
DOI: 10.1016/j.hoc.2015.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.PMID 26043391Read ↗

Atypical aHUS: State of the art.Semantic proximity Read ↗

Consensus regarding diagnosis and management of atypical hemolytic uremic syndromeSemantic proximity Read ↗

[Atypical hemolytic uremic syndrome].Semantic proximity Read ↗

A review of genetic and epigenetic biomarkers involved in the occurrence of atypical hemolytic uremic syndrome and its therapeutic strategies.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.Semantic proximity Read ↗

Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy.Semantic proximity Read ↗

Molecular basis of thrombotic microangiopathy.Semantic proximity Read ↗

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.Semantic proximity Read ↗

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndromeSemantic proximity Read ↗

Diagnosis and management of complement mediated thrombotic microangiopathies.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.